Shares of Orion Oyj (OTCMKTS:ORINF – Get Free Report) were up 16.6% on Thursday . The company traded as high as $92.05 and last traded at $92.05. 100 shares changed hands during trading, a decline of 91% from the average session volume of 1,080 shares. The stock had previously closed at $78.95.
Orion Oyj Price Performance
The business’s 50 day moving average is $83.12 and its 200-day moving average is $82.14.
About Orion Oyj
Orion Oyj is a Finland-based pharmaceutical and diagnostic products company that develops, manufactures and markets both human and veterinary medicines, diagnostic tests and active pharmaceutical ingredients. With a history dating back to its founding in 1917, the company has evolved into a diversified life science group, offering prescription and over-the-counter products for neurological, respiratory, cardiovascular and urological conditions, among others. Orion’s human pharmaceuticals portfolio includes well-known treatments for Parkinson’s disease, hormone therapy and erectile dysfunction, while its veterinary range addresses animal health needs such as pain management and dermatology.
In its Diagnostics segment, Orion produces laboratory tests and instruments for clinical chemistry and immunoassay applications, focusing on hormone and drug monitoring.
Recommended Stories
- Five stocks we like better than Orion Oyj
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
- American Eagle Goes on Sale: Is It Time to Buy?
Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
